(Q37901878)

25 August 2017

1 reference

title

Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial (English)

1 reference

multicenter clinical trial

25 August 2017

0 references

0 references

0 references

1 reference

25

1 reference

25 August 2017

Jennifer Hellier

2

0 references

Renee Romeo

Renee Romeo

4

0 references

Gill Livingston

Gill Livingston

14

0 references

Michael Dewey

Michael Dewey

3

0 references

Chris Fox

Chris Fox

8

0 references

Clive Ballard

Clive Ballard

5

0 references

Martin Knapp

11

Martin Knapp

1 reference

25 August 2017

Clive Holmes

9

0 references

Sube Banerjee

Sube Banerjee

1

0 references

John T. O'Brien

John O'Brien

20

0 references

Martin Orrell

19

Martin Orrell

1 reference

25 August 2017

10

Cornelius Katona

1 reference

25 August 2017

7

Peter Bentham

1 reference

25 August 2017

17

Joanna Murray

1 reference

25 August 2017

15

Niall McCrae

1 reference

25 August 2017

16

Esme Moniz-Cook

1 reference

25 August 2017

18

Shirley Nurock

1 reference

25 August 2017

21

Michaela Poppe

1 reference

25 August 2017

23

Rebecca Walwyn

1 reference

25 August 2017

Robert Baldwin

6

1 reference

25 August 2017

Claire Lawton

12

1 reference

25 August 2017

James Lindesay

13

1 reference

25 August 2017

Alan Thomas

22

1 reference

25 August 2017

Kenneth Wilson

24

1 reference

25 August 2017

language of work or name

English

0 references

publication date

19 July 2011

1 reference

25 August 2017

1 reference

25 August 2017

volume

378

1 reference

25 August 2017

issue

9789

1 reference

25 August 2017

page(s)

403-411

1 reference

Psychiatric phenomena in Alzheimer's disease. III: Disorders of mood

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Depression in dementia sufferers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Dementia with coexistent major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Double-blind trial of imipramine in Alzheimer's disease patients with and without depression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Sertraline for the treatment of depression in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

North of England evidence based guidelines development project: guideline for the primary care management of dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Cornell Scale for Depression in Dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Development of a new measure of health-related quality of life for people with dementia: DEMQOL.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

EuroQol--a new facility for the measurement of health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

1 reference

7 January 2021

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Relatives of the impaired elderly: correlates of feelings of burden.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Pathological verification of ischemic score in differentiation of dementias.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Depression in Alzheimer's disease. Pathophysiology, diagnosis, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

A European consensus on outcome measures for psychosocial intervention research in dementia care.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Improving the quality of care for mild to moderate dementia: an evaluation of the Croydon Memory Service Model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

Clinical and cost effectiveness of services for early diagnosis and intervention in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960830-1

7 January 2021

10.1016/S0140-6736(11)60830-1

Identifiers

DOI

1 reference

25 August 2017

1 reference